Vol 32, Issue 10 of the PEPNET E-Newsletter: "New Product Line Introduced"

Do you want economical or high-purity long peptides? How about both! A new product line is introduced to address just that, The Rare Disease Journal returns with a look at Kawasaki Disease, plus much more this issue.

Our latest issue of New England Peptide | Peptides International's PEPNET e-newsletter is available HERE.

Would you like to receive the PEPNET e-newsletter too - directly to your in-box?  Sign up HERE.

https://www.pepnet.com/res/uploads/media//PEPNET_2020_masthead.jpg

Testimonials

"Over the past 8 years we have used NEP for synthesis of many hundreds of peptides. The quality of NEP’s product is consistently very high. The company is deeply knowledgeable in all aspects of peptide synthesis, highly collaborative, and keenly interested in meeting the changing needs of their customers with respect to scale and formatting for delivery of peptides. One example is their flash-purified product which meets the need for initial draft-level evaluation without breaking the bank. Our experience with NEP’s antibody production capabilities has also been very good..."
Steven Carr, PhD - Director of Proteomics, Broad Institute